GS vs SCYX · P/E 20, rev $58.28B vs rev $235.0K
Goldman Sachs Group Inc (GS) versus Scynexis Inc (SCYX) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David M. Solomon.
Scynexis Inc (SCYX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GS revenue for 2025-12-31 was $58.28B. Net income was $17.18B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Latest reported SCYX revenue for 2026-06-30 was $235.0K. Net income was $7.4M. SCYX currently screens at market cap $37.7M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. SCYX currently screens at market cap $37.7M.
Not investment advice. Open the GS and SCYX stock pages for the full models.
Not investment advice.